AVITA Medical, Inc. (RCEL) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $12.79M | +40.7% |
| 2024 | $9.09M | +16.9% |
| 2023 | $7.78M | +28.8% |
| 2022 | $6.04M | +1.5% |
| 2021 | $5.95M | +100.1% |
| 2020 | $2.97M | +133.9% |
| 2019 | $1.27M | +132.8% |
| 2018 | $546.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $12.79M | +40.7% |
| 2024 | $9.09M | +16.9% |
| 2023 | $7.78M | +28.8% |
| 2022 | $6.04M | +1.5% |
| 2021 | $5.95M | +100.1% |
| 2020 | $2.97M | +133.9% |
| 2019 | $1.27M | +132.8% |
| 2018 | $546.0K | — |